The aim of this study was to investigate the effect of Poly(amidoamine) (PAMAM) dendrimers on corneal permeation of puerarin (PUE). Permeation studies were performed using excised cornea of rabbits by a Valia-Chien diffusion apparatus. Drug-treatment studies were carried out by measuring the penetration of puerarin on cornea in PAMAM-PUE physical mixture or PAMAM-PUE complex, and cornea-treatment studies were carried out by measuring the penetration of puerarin on PAMAM dendrimer pretreated cornea in puerarin solution. The results showed that the permeability coefficient of puerarin in PAMAM-PUE physical mixture was enhanced by 2.48 (G3), 1.99 (G4) and 1.36 (G5) times on average, respectively compared to control. However, no significant permeability enhancement of puerarin in PAMAM-PUE complex was found compared to control. This may attribute to free drug concentration was lower in PAMAM-PUE complex which served as a depot and exhibited slow-released behavior of drug. Cornea-treatment studies showed that the lag time of puerarin was decreased, while the cumulative amount within 2.5 h (Q 2.5 ) and the permeability coefficient of puerarin increased compared to control. The permeability coefficient of puerarin was linear correlated to the molecular weight of PAMAM dendrimer (r 2 ‫.)99.0؍‬ This indicates that higher generation of PAMAM dendrimer more easily interact with cornea or loosen the epithelium cell junctions than lower generation to increase the flux of puerarin. Overall, the study showed that PAMAM dendrimer increased the corneal permeation of puerarin mainly by altering the corneal barrier.
For any drug, efficacy is of great importance. However, efficacy of the drug may often be reduced because of the inability to deliver the drug to the specific cells and tissues. In ocular drug delivery, most ophthalmic drugs are administrated topically in form of eye drops. Unfortunately, due to the special anatomic structure and efficient protective mechanisms, the eye drops are rapidly drained from the ocular surface and, therefore, the time for drug absorption is only a few minutes and bioavailability is very low, typically less than 5%. 1) In order to enhance the ocular bioavailability, many ophthalmic drugs are applied in high concentrations or increased frequency of administration, but these may cause both ocular and systemic side-effects. 2) Recently, various new carrier and technology have been explored to improve the ocular bioavailability of drugs by increasing the precorneal residence time and/or penetration ability of the active ingredient. For example, bioadhesive polymer such as chitosan, hyaluronic acid, cellulose derivatives and various temperature, pH and ion induced in situ-forming hydrogen have been used as ophthalmic delivery systems to prolong the contact time of drug with the cornea via enhanced viscosity and mucoadhesive propertys. [3] [4] [5] Colloidal system including liposome and nanoparticle has been shown to prolong activity and provide site-specific delivery via improved affinity with cornea. 6, 7) On the other hand, an ophthalmic drug delivery system based on corneal penetration enhancement has been proved to improve ocular bioavailability by adding chemical permeation enhancer. So far most of corneal permeation enhancer are small molecules or linear polymers. 3, 4, 6, 8) The corneal penetration enhancement of branched dendritic polymers is unknown although its permeability enhancement in cell culture model, intestinal membranes and skin have been proved. [9] [10] [11] [12] [13] The present study focuses on evaluating dendrimers as corneal penetration enhancer. Dendrimers were reported for the first time in the early 1980s 14) and now have attracted increasing attention for their applications in many fields. Dendrimers are highly branched three-dimensional macromolecules with well-defined shapes, and surface controllable functionalities. Poly(amidoamine) (PAMAM) dendrimers are commercially available and are synthesized using a small organic molecule ethylenediamine as core and stepwise addition of branches to the core. 15) They have hydrophilic exteriors and hydrophobic interiors, which are responsible for its unimolecular micellar nature. 16) Hydrophobic drugs [17] [18] [19] can be encapsulated within the nonpolar interiors cavities to make them water-soluble and/or drugs can be complexed or covalently coupled onto the periphery of the dendrimers. [20] [21] [22] [23] PAMAM dendrimers of different generations have proved to be excellent solubility enhancers, effective sustained release containers 24) and so on. Recently, some studies showed that a distinct advantage of dendrimers is the high density of surface functional groups that can undergo multivalent interactions with the biological membranes and drugs. 25) Kitchens also found that their spherical architecture provides a compact structure with a small hydrodynamic radius for transport across biological membranes. 9) Due to these unique features, dendrimers are widely investigated as drug and gene carriers by various routes of administration. 10) To address this issue, studies in cell culture and intestinal membranes have shown that dendrimer increase the permeation by interacting with the membrane lipids. 9, 11) Some studies have shown that dendrimers increase the skin permeation of lipophilic drugs by increasing their water solubility. 13, 14) Vandamme and Brobeck 26) have reported the development of PAMAM dendrimers as ophthalmic vehicles in ocular delivery systems. The results showed that PAMAM dendrimer can increase corneal residence time of pilocarpine nitrate and tropicamide. However, what effect of PAMAM dendrimers on corneal penetration has not been reported yet.
The purpose of the present study is to investigate the effect of PAMAM dendrimers on corneal permeation of puerarin as a model drug. Puerarin is an isoflavone compound extracted from the radix of Pueraria lobata (WILLD.) OHWI. 27) As a result of its ability to lower intraocular pressure, and improve ocular blood flow, it is frequently used as a therapeutic agent for cataracta glauca and ocular hypertension in China. However, due to its poor solubility and permeability across biomembrane, there also exist problems such as lower bioavailability and systemic absorption which were common questions of most eye drops. 28, 29) In our study, the mechanism of corneal permeation enhancement of PAMAM dendrimer was also discussed.
MATERIALS AND METHODS

Materials and Animals
The PAMAM dendrimers with primary amine (G3, G4, G5) and carboxylate (G3.5, G4.5) surface groups in solution in methyl alcohol were synthesized by Dendritech ® (Midland, Michigan) and purchased from Sigma-Aldrich (St. Quentin Fallavier, France). The puerarin was purchased from Shanghai DND Pharm-Technology Co., Inc. (Shanghai, China). The oxidized glutathione was purchased from Beijing Yili Fine Chemicals Co., Ltd. (Beijing, China). All others chemicals were of reagent grade from commercial sources.
New Zealand albino rabbits were obtained from the experimental animal center of Luye Pharma, Yantai, China. The experimental animals weighed between 2.5 and 3.0 kg. The animals were housed in standard cages in a light-controlled room at (19Ϯ1)°C and (50Ϯ5)% relative humidity separately, and given a standard pellet diet and water. All animals were healthy and free of clinically observable ocular abnormalities and approved by the Animal Ethical Committee at Yantai University for animal experimentation.
Methods. Preparation of Samples Puerarin Solution: The puerarin (5 mg) was dissolved in 5 ml phosphate buffer solution with a pH of 7.4 to achieve puerarin solution.
Physical Mixture of PAMAM Dendrimer and Puerarin: The puerarin (5 mg) and the dendrimer (2.5 mg) were dissolved in 5 ml phosphate buffer solution with a pH of 7.4 to achieve physical mixture solution of PAMAM dendrimer and puerarin which was called PAMAM-PUE physical mixture for short. The PAMAM-PUE physical mixture was freshly prepared only before in drug corneal permeation studies.
Complex of PAMAM Dendrimer and Puerarin: The puerarin (5 mg) was dissolved in 2 ml methanol following which the dendrimer (2.5 mg) was added. The reaction mixture was stirred for 24 h in the dark, then evaporated using rotary evaporator to remove methanol. Subsequently, deionized water was added to the residue. The solution was stirred in the dark for 12 h. Then ultrafiltration method was used in order to separate the free puerarin from the PAMAM-PUE complex. The complex solution was lyophilized to remove water. 30) The complex obtained was in the form of a white powder. Then, the complex was dissolved in 5 ml phosphate buffer solution with a pH of 7.4 to achieve the solution of PAMAM dendrimer and puerarin complex which was called PAMAM-PUE complex for short. The PAMAM-PUE complexes solution were freshly prepared only before in drug corneal permeation studies.
Preparation of Excised Cornea
The rabbits were euthanized with an intravenous lethal dose of sodium pentobarbital. The whole eyes were enucleated from their sockets and corneas with 2 mm ring of sclera were immediately excised, where the cornea area available for diffusion was 0.785 cm 2 . Various ocular tissues were dissected from the corneas, which then were washed with distilled water, and preserved in the glutathione bicarbonate ringer (GBR) buffer. The penetrative experiments in vitro must be initiated within 20 min of dissection.
In Vitro Permeability Studies The experiments were performed by Valia-Chien perfusion cell, which include donor and reservoir chambers. The GBR buffer was used as a releasing medium. 31, 32) The isolated cornea was clamped between two compartments of the perfusion chambers, so that the epidermis faced the donor chamber. Five milliliters preheated (37°C) GBR buffer was added to the reservoir chamber and 4.5 ml sample solution was then added to the donor chamber. The perfusion chambers were placed on the magnetic stirrer and thermostated by circulating at a constant water temperature (35Ϯ 1)°C (the surface temperature of the cornea). To insure mixing and oxygenation, an O 2 : CO 2 (95 : 5) mixture was bubbled through each compartment at a rate of 2-3 bubbles aided by magnetic stir bars. Two hundreds microliters samples were withdrawn from the reservoir chamber at regular time intervals up to 2.5 h. Each sample was immediately replaced with an equal volume of GBR buffer to maintain a constant volume. The collected sample solution was centrifuged at 17530 g for 10 min, then 20 ml of supernate was injected into the high-performance liquid chromatography (HPLC) system. The amount of puerarin permeated across the cornea and the permeability parameters were calculated.
PAMAM Dendrimer Treatment To evaluate the effect of PAMAM dendrimer on the drug and cornea. Drug-treatment and cornea-treatment studies were performed, respectively. In drug-treatment studies, PAMAM-PUE physical mixture and PAMAM-PUE complex were applied on the cornea. The control was puerarin solution. In cornea-treatment studies, the cornea was treated with 2 ml PAMAM dendrimer (0.2%, w/v) in GBR solution for 30 min, after the dendrimer was completely removed, the puerarin solution was applied on the treated cornea. Control cornea was treated with plain GBR solution for a similar time period in the studies.
HPLC Conditions
The chromatographic system consisted of Agilent 1100 HPLC (Agilent, U.S.A.) and a UV detector. The HPLC separation was performed on reverse phase C18 columns (5 mm, 250ϫ4.6 mm, Kromasil, Sweden). The mobile phase consisted of a mixture of methanol and 0.1% citric acid (35 : 65, v/v). The mobile phase was filter through a 0.45 mm microporous membrane and was deaerated ultrasonically prior to use. The detector was set at 249 nm and the flow rate was set at 1 ml/min. The column temperature was set at 30°C.
Data Analysis The corneal permeation parameters were calculated from the plot of cumulative amount of puerarin permeated as a function of time. The accumulated amounts of puerarin permeated across the cornea were calculated by the following equation:
Q: the accumulated permeation amount within time t, C n : the measured concentration value within time t, V 0 : the total volume of solution in the reservoir chamber, V: the sampling volume per time point, C i : the measured value of concentration before time t.
Apparent permeability coefficient (P app ) was calculated from the slope of linear portion of the curve and the lag time (t lag ) was calculated by extrapolating the linear portion of the curve to the time axis. The correlation coefficient of linear portion of the curve was Ͼ0.99. P app can be calculated by the following formula:
C 0 : the concentration of the drug in the vehicle, A: significant area of the cornea, DQ/Dt: the slope rate of the steady state in Q-t plot.
Diffusion coefficient (D) was calculated using the following equation: Dϭd 2 /6t lag . d is the cornea thickness (0.0625 cm). 33, 34) Enhancement ratio (ER) was calculated by dividing the permeability coefficient of puerarin in PAMAM dendrimer treatment with the permeability coefficient of puerarin in control. Diffusivity ratio (DR) was calculated similarly by using the values in presence and absence of dendrimer.
Results are reported as the meanϮS.D. Student's t-test was used to identify differences which were considered to be statistically significantly at pϽ0.05 and pϽ0.01.
RESULTS
Influence of PAMAM Dendrimer in PAMAM-PUE Physical Mixture on Permeation
The PAMAM dendrimers used in the study are shown in Table 1 . G3, G4 and G5 PAMAM dendrimers have the same amine (-NH 2 ) surface functional groups. The number of surface groups increases exponentially with an increase in generation of dendrimers. Therefore, all the three dendrimers were used to study the effect of dendrimer generations on drug permeation. G3.5 and G4 as well as G4.5 and G5 PAMAM dendrimers have the same number of surface functional groups, whereas the surface groups were different. Therefore, they are used to study the role of surface charge on drug permeation.
The cumulative amounts of puerarin permeated across excised rabbit corneas in PAMAM-PUE physical mixture were shown in Fig. 1 . Corneal permeation parameters of puerarin were shown in Table 2 . The results showed that the permeability coefficient of puerarin in PAMAM-PUE physical mixtures were all increased compared to control, and different generation of PAMAM dendrimers exhibited different permeation parameters. The permeability coefficient of puerarin was enhanced by 2.48 (G3), 1.99 (G4) and 1.36 (G5) times on average, respectively. Cumulative amount of puerarin permeated within 2.5 h (Q 2.5 ) was in the following decreasing order G3ϾG4ϾG5 among the three cationic dendrimers. The lag time (t lag ) of puerarin with G3 and G4 PAMAM dendrimers was increased, while no significant difference with G5 PAMAM dendrimer compared to control. Because of the corneal thickness was certain, the shorter lag time resulted in the larger diffusion coefficient. ER and DR represent the extent of drug permeability and diffusion enhancement after dendrimers treated the drug, respectively. ER was plotted against DR in Fig. 2 , it can be seen that ER was inversely related to DR (r 2 ϭ0.9). The higher diffusion coefficient enhancement, the lower permeability coefficient enhancement. This may attribute to the lower of the partition coefficient because the permeability coefficient is a product of partition coefficient and diffusion coefficient divided by the cornea thickness.
35) The partition coefficient is a product of drug concentration in cornea divided by the drug concentration in vehicle. This indicates that the concentration of drug in vehicle is larger than that in cornea, that is to say, the interaction between drug and higher generation of PAMAM dendrimer is more stronger than that between drug and cornea. The G3.5 and G4 PAMAM dendrimers with similar interior structure and differert surface groups (Table 1) were used to investigate the role of surface charge on drug permeation. The results showed that the permeability coefficient of puerarin in G4 PAMAM dendrimer physical mixture was higher than G3.5 PAMAM dendrimer.
Influence of Ratio between PAMAM Dendrimer and Puerarin in PAMAM-PUE Physical Mixture on Permeation Since G3 PAMAM dendrimer showed higher permeability enhancement, the effect of ratio between G3 PAMAM dendrimer and puerarin on corneal permeation was investigated ( Fig. 3) . At low concentration of PAMAM dendrimer, the permeability coefficient of puerarin increases with the concentration of PAMAM dendrimer increased. Under these conditions, the drug is almost disassociated from PAMAM dendrimer in the donor phase, thus, the thermodynamic activity of the drug is at its maximum (i.e., the drug has maximum tendency to partition into the ocular barrier). 29, 36) At high concentrations of PAMAM dendrimer, the permeability coefficient reached to be steady or decreased due to decreasing the drug activity in donor phase. Under these conditions, part of drugs may be encapsulated into the PAMAM dendrimer interior. Therefore, as the concentration of PAMAM increased, the thermodynamic activity of puerarin decreases, which leads to the steady or decrease of permeability coefficient of puerarin. 29, 36) Overall, the permeation of puerarin on corneal permeation was related to the ratio between puerarin and PAMAM dendrimer.
Influence of PAMAM Dendrimer in PAMAM-PUE Complex on Permeation
The cumulative amounts of puerarin premeated across excised rabbit corneas in PAMAM-PUE complex were shown in Fig. 4 . The permeation parameters of puerarin calculated on cornea were shown in Table 3 . The permeability coefficient and cumulative amount of puerarin within 2.5 h in PAMAM-PUE complexes were similar to control. On the other hand, the lag time of puerarin was decreased with G3, G4 and G5 PAMAM dendrimers, but there was no significant difference among them. This may attribute that PAMAM-PUE complex may serve as a depot, unlike the PAMAM-PUE physical mixture, most of the puerarin molecules were complexed with PAMAM dendrimers and it must be released from the PAMAM-PUE complex before penetrated across the cornea.
Influence of PAMAM Dendrimer Treated Cornea on Permeation To investigate the interaction of PAMAM dendrimer with cornea and the role of PAMAM dendrimer in permeation enhancement, the cornea was pre-treated with PAMAM dendrimer and then used in vitro permeability studies. The cumulative amounts of puerarin premeated across excised rabbit corneas were shown in Fig. 5 . The permeation parameters of puerarin calculated on cornea were shown in 1374 Vol. 33, No. 8 Table 4 . After cornea was treated with PAMAM dendrimers, the lag time of puerarin was decreased, while the cumulative amount within 2.5 h (Q 2.5 ) and the permeability coefficient of puerarin increased, compared to control. ER and DR represent the extent of drug permeability and diffusion enhancement after dendrimers pre-treated the cornea, respectively. ER was plotted against DR in Fig. 6 . It can be seen that ER was increased linearly with DR (r 2 ϭ0.9) (Fig. 6 ). The higher diffusion coefficient enhancement, the larger permeability coefficient enhancement. After different generation of PAMAM dendrimer pretreated the cornea, puerarin solution was applied on the cornea. This indicates that the permeability coefficient enhancement was mainly caused by PAMAM dendrimers pre-treated the cornea. For PAMAM dendrimers, the more number of surface groups, the larger molecular weight ( Table 1 ). The interaction between dendrimers and cornea was stronger with the more number of surface groups. In order to delineate the interaction between dendrimers and cornea, the permeability coefficient was plotted against the molecular weight (number of surface groups) of PAMAM dendrimers in Fig. 7 . It can be seen that the permeability coefficient was correlation to the molecular weight of PAMAM dendrimer (r 2 ϭ0.9) (Fig. 7) . The larger molecular weight of dendrimer as well as the more number of surface groups, the larger drug permeability coefficient. This indicated that higher generation of dendrimer was easier to interact with cornea or loosen the epithelium cell junctions than lower generation of dendrimers, and resulted in the lag time shortened and the flux increased. In pre-treated cornea studies, after G5 PAMAM dendrimer pre-treated the cornea, the results showed higher drug permeability coefficient. The G4.5 and G5 PAMAM dendrimers have the same number of surface groups whereas which were different (Table 1) . Therefore, they were used to investigate the role of surface charge on drug permeation in this study. After G5 PAMAM dendrimer pretreated the cornea, the lag time of puerarin permeation was lower, while the permeability coefficient was higher, compared to G4.5 PAMAM dendrimer. This indicated that positive charged surface functional groups (-NH 2 ) can easier contact with the negatively charged cornea to increase the permeability coefficient of the drug.
DISCUSSION
It is well known that the ability of substances to diffuse through epithelial barriers depends not only on the properties of the barriers involved but also on the chemical nature, size, lipid/water partition coefficient, and degree of ionization of the permeant molecules tested. 37) To the compounds with poor transport property, the permeation can been improved by proper vehicle and technology. Puerarin is an isoflavone compound and frequently used as a therapeutic agent for cataracta glauca because of its ability to lower intraocular pressure, improve ocular blood flow and so on. However, its clinical applications was hindered due to its poorly soluble in water (the aqueous solubility of about 4 mg/ml), lower lipid/water partition coefficient and bioavailability. 38) Generally, PVP was used as solubilizer for 1% puerarin eye drops. Wu et al. have shown that 4.3% PVP can improve puerarin solubility (1.30%). 39) In our present study, we have found that PAMAM dendrimer can also improve the solubility of puerarin, and the solubility of puerarin was increased with the concentration of PAMAM dendrimer increased (unpublished Results). Besides, dendrimers are branched polymers with a high density of functional groups which can undergo multivalent interactions with drug and biological membranes. To this end, the main objective of the present study is to understand the effect of dendrimer as ocular carrier on cornea transport of model drug puerarin.
In our corneal permeation studies, drug-treatment was studied to evaluate the effect of PAMAM dendrimer on the drug. In general, there exist three types interactions between drug and PAMAM dendrimer in carrier system: simple encapsulations, electrostatic interactions and covalent conjugations. 10) For PAMAM-PUE physical mixture, most of puerarin was free from PAMAM dendrimer or weak interact with PAMAM dendrimer, such as electrostatic interactions, that is to say, only small parts of drug were encapsulated in PAMAM dendrimer. On the other hand, for PAMAM-PUE complex, almost all puerarin molecules were encapsulated in the interior of PAMAM dendrimer and formed hydrogen between hydroxy group of puerarin and the amine group of PAMAM dendrimer (unpublished Results). It is important to say that drug must be release from PAMAM dendrimer before transport across cornea. As the result of PAMAM-PUE physical mixture, cumulative amount and permeability coefficient of puerarin were increased and in the following decreasing order G3ϾG4ϾG5. As we all known, the cavity of high generation PAMAM dendrimer was larger than the one of low generation PAMAM dendrimer, the amount of drug encapsulated into the higher generation PAMAM dendrimer was more than one of lower generation. Therefore, free drug concentration in low generatrion PAMAM-PUE physical mixture was larger than high generation during the permeation experiments, which resulted in that the corneal permeation enhancement of puerarin in low generation PAMAM-PUE physical mixture is better than in one of high generation. On the other hand, according to the results above, the cumulative amount and the permeability coefficient of puerarin permeated in PAMAM-PUE complex showed no significant difference compared to control, that is due to the concentration of free puerarin on corneal permeation studies was lower. PAMAM-PUE complex served as a depot and drug was slow released from PAMAM-PUE complex. Overall, PAMAM dendrimer increased the drug corneal penetration by increasing the solubility of puerarin in PAMAM-PUE physical mixture and/or PAMAM-PUE complex, and PAMAM-PUE physical mixture manily increased the free drug concentration which plays an important role in drug corneal permeation.
In order to explore the role of PAMAM dendrimer on corneal permeation enhancement, the dendrimers pretreated cornea were used in the permeation studies to delineate the cornea-dendrimer interactions independent of the dendrimerdrug interactions. Cationic dendrimers are known to interact with negatively charged biological membranes and increase its permeability. 35, 40, 41) Cornea is negatively charged at physiological pH value 42) and hence cationic dendrimer is expected to interact with the cornea. In present study, after high generation of PAMAM dendrimer pretreatment, the cumulative amount of puerarin permeated was enhanced compared to control. The permeability coefficient of puerarin was related to the molecular weight of PAMAM dendrimer. On the other hand, the lag time of puerarin was decreased, and the permability coefficient enhancement was linearly related to the diffusion coefficient ratio compared to control (Fig. 7) . This may attribute that PAMAM dendrimer may incorporate into the lipid bilayer in the outer cell membrane of corneal epithelial cells and higher generation of PAMAM dendrimer may easier loosen the epithelium cell junctions than lower generations. Some studies have also shown that an increase in dendrimer generation cause greater perturbation of cell membranes and model lipid membranes and greater changes in cell permeability. 43, 44) Similarly, Mecke et al. 45) have also shown that cationic dendrimers induce hole formation in model lipid bilayers and cell membranes, and greater changes in dimyristyl phosphatidyl choline lipid bilayers with higher generation dendrimers. Overall, PAMAM dendrimer may loosen the epithelium cell junctions, forming polar defects which change the physical properties of the cell membrane, accordingly changing the structure of the epithelium and leading to membrane solubilization and cornea solubilization.
The percentage corneal hydration is frequently used as a parameter to evaluate damage to this tissue. The normal cornea has a hydration level of 76-80%. 46) As is indicated, a hydration level that is 3-7% units above the normal value denotes damage to the epithelium and/or endothelium. In our studies, the corneal hydration levels were determined lower than 79% (data not shown) when each permeation test was over, Which indicate that the dendrimer did not cause any damage to the epithelium and/or endothelium during the studies.
In summary, the mechanism of corneal permeation enhancement of PAMAM dendrimer for puerarin is that PAMAM dendrimer be able to incorporate into the lipid bilayer in the outer cell membrane of corneal epithelial cells and loosen the epithelium cell junctions of cornea and then the drug free from PAMAM dendrimer or released from PAMAM dendrimer complex transported across the cornea by paracellular pathway. CONCLUSION PAMAM dendrimer is able to increase the corneal permeation of puerarin which enhancement was related to the molecular weight of PAMAM dendrimer and type of carrier of PAMAM dendrimer and puerarin. The mechanism of corneal permeation enhancement of PAMAM dendrimer for puerarin is that PAMAM dendrimer be able to increase the solubility of puerarin resulted in the larger free drug concentration which plays an important role in drug corneal penetration, and PAMAM dendrimer be able to incorporate into the lipid bilayer in the outer cell membrane of corneal epithelial cells and loosen the epithelium cell junctions of cornea. PAMAM dendrimer is promising to serve as a corneal permeation enhancer in ophthalmic drug delivery system.
